Steven P. DenBaars's most recent trade in Aeluma Inc was a trade of 12,500 Common Stock done at an average price of $13.8 . Disclosure was reported to the exchange on Aug. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 13.82 per share. | 26 Aug 2026 | 12,500 | 345,209 | - | 13.8 | 172,698 | Common Stock |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 13.84 per share. | 26 Aug 2026 | 12,500 | 357,709 | - | 13.8 | 173,044 | Common Stock |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 13.84 per share. | 26 Aug 2026 | 12,500 | 357,709 | - | 13.8 | 173,044 | - |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 13.82 per share. | 26 Aug 2026 | 12,500 | 345,209 | - | 13.8 | 172,698 | - |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 20.40 per share. | 19 May 2026 | 11,558 | 371,151 | - | 20.4 | 235,734 | Common Stock |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 19.56 per share. | 19 May 2026 | 7,415 | 387,794 | - | 19.6 | 145,026 | Common Stock |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 20.61 per share. | 19 May 2026 | 5,085 | 382,709 | - | 20.6 | 104,807 | Common Stock |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 21.30 per share. | 19 May 2026 | 942 | 370,209 | - | 21.3 | 20,064 | Common Stock |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 15.85 per share. | 25 Feb 2026 | 12,500 | 385,088 | - | 15.8 | 198,094 | Common Stock |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Sale of securities on an exchange or to another person at price $ 17.58 per share. | 25 Feb 2026 | 12,500 | 397,588 | - | 17.6 | 219,766 | Common Stock |
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2025 | 10,121 | 395,209 | - | 0 | Common Stock | |
| SmartKem Inc | Dr. Steven P. DenBaars, PhD | Director | 03 Sep 2025 | 22,466 | 22,466 | - | - | Stock Option (right to buy) | ||
| SmartKem Inc | Dr. Steven P. DenBaars, PhD | Director | 28 May 2025 | 23,915 | 23,915 | - | - | Stock Option (right to Buy) | ||
| Aeluma Inc | Dr. Steven P. DenBaars, PhD | Director | 10 Jan 2025 | 84,663 | 127,942 | - | - | Stock Option | ||
| SmartKem Inc | Dr. Steven P. DenBaars, PhD | Director | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | ||
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 18 Aug 2023 | 7,000 | 287,709 (0%) | 0% | 1.8 | 12,810 | Common Stock |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Grant, award, or other acquisition of securities at price $ 2.75 per share. | 24 Jan 2023 | 18,182 | 294,709 (0%) | 0% | 2.8 | 50,001 | Common Stock |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 06 Dec 2022 | 7,000 | 276,527 (0%) | 0% | 3.6 | 24,990 | Common Stock |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 39,982 | 283,527 (0%) | 0% | 0 | Common Stock | |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Sale of securities on an exchange or to another person at price $ 3.90 per share. | 06 Sep 2022 | 7,000 | 243,545 (0%) | 0% | 3.9 | 27,300 | Common Stock |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 06 Jun 2022 | 7,000 | 250,545 (0%) | 0% | 4.5 | 31,360 | Common Stock |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 8,013 | 24,719 | - | - | Stock Option (Right to Buy) | |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.24 per share. | 14 Feb 2022 | 8,013 | 257,545 (0%) | 0% | 6.2 | 50,001 | Common Stock |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Sale of securities on an exchange or to another person at price $ 5.91 per share. | 11 Jan 2022 | 7,000 | 249,532 (0%) | 0% | 5.9 | 41,370 | Common Stock |
| Akoustis Technologies Inc | Steven P. DenBaars | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 16,703 | 256,532 (0%) | 0% | 0 | Common Stock |